For the second time in a week, a long-standing conjecture has been disproved by artificial intelligence, highlighting the advanced mathematical capabilities of ChatGPT and its ilk
Get the latest international news and world events from around the world.
Protein excess tips the balance of cellular health
For cells to function properly, they must produce the right amount of each protein. It is a delicate balance: both too little and too much can compromise essential cellular functions. A research team has now shown that even a modest excess of tubulin – the protein that assembles into microtubules, the cell’s internal scaffolding – is enough to disrupt tissue architecture and reduce cell viability. Published in Nature Communications, the study demonstrates that the quantity of a protein is just as important as its function.
Microtubules, built from tubulin, form the cell’s internal skeleton. They help cells maintain their shape, transport molecules, divide, and remain firmly attached to neighbouring cells. Rather than being rigid structures, microtubules are constantly assembled and disassembled to adapt to the cell’s changing needs. This dynamic behavior depends directly on the amount of tubulin available.
For more than forty years, biologists have known that cells possess a mechanism that slows tubulin production when its levels become too high. However, the biological purpose of this regulatory pathway remained unknown. To address this question, the team used three-dimensional spheroids. “These 3D cell culture models behave like tissues and reproduce cell-cell interactions much more faithfully than conventional two-dimensional cultures,” the author explains.
3D multiomics tumour atlases: from technology to biology and clinical translation Reviews Cancer
In this Review, Liu et al. describe the established and emerging tools for the generation of comprehensive 3D tumour atlases, the analysis of which has the potential to uncover novel biomarkers for risk stratification, early detection, preventive interventions, and transformative diagnostic and treatment strategies.
Rotating metamaterial units could enable long-range wave control beyond conventional limits
A Seoul National University College of Engineering research team, led by Professor Joo Hwan Oh of the Department of Mechanical Engineering, in collaboration with Dr. Myung Hwan Bae of the Korea Research Institute of Standards and Science (KRISS), has developed a new elastic metamaterial platform that enables the free design of how externally applied forces and vibrations propagate.
The team proposed a design principle that allows nonlocal metamaterials—in which forces or vibrations applied in one region can interact not only with adjacent areas but also with distant regions—to be more easily extended into diverse structural configurations.
They demonstrated experimentally that this design overcomes the longstanding issue of interference among multiple vibrations in conventional nonlocal metamaterials, enabling more precise control of the propagation and motion of elastic waves.
Butterfly gliomas: to biopsy or to ablate cohort study NeuroOncology
Butterfly gliomas are an aggressive subset of high-grade glioma characterized by bilateral hemispheric involvement. These patients often only receive biopsy followed by chemoradiation rather than surgical resection. Laser interstitial thermal therapy (LITT) provides a minimally invasive alternative that can improve survival.
We retrospectively compare outcomes in biopsy alone versus LITT cohorts. Demographic characteristics, perioperative outcomes, and survival metrics were analyzed. Within the LITT cohort, procedural and volumetric analyses were performed to examine the relationship between extent of ablation (EOA), residual tumor burden (RTB).
Of 44 patients, 15 underwent biopsy only and 29 received LITT was associated with a longer median overall survival compared to biopsy (14.86 versus 4.93 months, p = 0.0489), and median progression-free survival (4.67 versus 2.53 months, p = 0.0389). Within the LITT cohort, larger preoperative tumor volumes were associated with lower EOA (r²=0.46, p = 0.0002) and a higher RTB (r2 = 0.90, p = 0.0001). Longer ablation times correlated with a larger EOA (r2 = 0.21, p = 0.0320). Neither EOA nor RTB were associated with survival. Postoperative KPS improvement correlated with improved OS after multivariable Cox proportional hazards analysis (HR (death) = 0.93, 95%CI:0.87–0.99, p = 0.026), with a similar trend in PFS. Total operating room time was longer in the LITT group (median 4.0 vs. 2.57 h, p = 0.0034), while time-to-chemoradiation, ICU stay, and hospital stay were comparable. Post-operative re-admissions and complications were not statistically different between groups.
CRISPR-Cas orchestrates a layered defense network to fight bacterial viruses
All cellular life-from humans to bacteria-possesses two layers of immunity: innate and adaptive. Scientists have long understood how these two types of immunity work together in higher organisms but not in the microbial world.
Bacteria and archaea use CRISPR-Cas as their sole form of adaptive immunity-a precise, sequence-specific defense that remembers past invaders. But what about innate immunity? Now, a study led by Prof. LI Ming from the Institute of Microbiology of the Chinese Academy of Sciences (CAS) reveals that CRISPR-Cas plays a broader role. Rather than acting alone like a solitary sniper shooting at phages, it also serves as a central command center, directing a network of diverse innate immune systems.
This work was published in Nature on July 22.
Age-Reversing Stem Cell Treatment Succeeds in Human Trial | Dr Koji Tanabe
Discover how original Yamanaka co-author Dr. Koji Tanabe uses automated iPSC cassettes and autologous stem cell secretomes to reverse cellular aging and repair damaged joints.
Some links are affiliate links so we will earn a commission when they are used to purchase products.
🧬 SUPPORT THE CHANNEL & LONGEVITY PARTNERS
If you would like to support our channel please consider joining our Patreon / modernhealthspan.
~~~~~~~~~~~~~~
Renue By Science (10% off: MHS) https://tinyurl.com/bdew4bfs NMN Powder • Lipo NR
BiOptimizers (15% off: MHBIO) https://bit.ly/47VAa8f — Magnesium Breakthrough, Gluten Guardian.
Seeking Health (10% off: Richard10) https://crrnt.app/SEEK/-dm0MyrQ, Histamine Nutrients https://crrnt.app/SEEK/EpM7paAO
Stemregen (15% off: MODERN) US only https://tinyurl.com/45z968yr.
AX3 Life (20% off: MODERN20) https://tinyurl.com/2t3w26nw — Astaxanthin.
Viome Full Body Intelligence https://viomehq.sjv.io/X4rkBg.
n1o1 (10% off: Modern) https://tidd.ly/3IczGRW — Nitric Oxide Lozenges.
Qualia (15% off: MODERN) Creatine+ https://tinyurl.com/mr3z35jd Senolytic https://bit.ly/4jlaibe.
Qitone (10% off: HEALTH10) https://tidd.ly/4jGklry Qitone Esters Powder.
MitoQ https://tinyurl.com/5n93fm3f MitoQ Pure https://tinyurl.com/3hxy9s7x.
Wellness Extract (10% off: MODERNWE) http://wellnessextract.com/RICHARDWE Geranylgeraniol • Vit E
Oxford Healthspan (15% off: MHS) https://tinyurl.com/hrxfnzpn — Spermidine.
ProHealth (15% off: MODERN) https://prohealth.pxf.io/aObQRR NMNH 500mg.
~~~~~~~~~~~~~~
In this landmark episode of Modern Healthspan, we sit down with Dr. Koji Tanabe, founder and CEO of iPS, Inc. and co-author of the historic 2007 Nobel Prize-winning paper on human-induced pluripotent stem cells (iPSCs). Dr. Tanabe shares how twenty years of technological advancement have raised iPSC reprogramming efficiency from under 1% to over 80%, while cutting manufacturing costs through automated cleanroom cassettes. We discuss practical longevity applications available today, including autologous stem cell banking from a simple blood draw, secretome extract therapies for joint and skin rejuvenation, and Japan’s approval of iPSC-derived heart tissue. Finally, Dr. Tanabe offers a critical scientific perspective on in vivo partial reprogramming, detailing the cellular identity loss and tumor risks associated with OSK gene delivery. Watch now to learn where stem cell age reversal truly stands today.
📚 Chapters.
00:00 — How the 2007 Yamanaka Breakthrough Reverses Cell Age.
09:58 — Cellular Reprogramming in Nature (Salamanders & Limbs)
15:01 — From 1% to 90%: Scaling Transfection Efficiency.
19:57 — Mass Production: Automated Cassettes for Stem Cells.
24:57 — Slashed Costs: Disrupting the $10M Treatment Price Tag.
29:58 — Retrovirus Danger: Preventing Toxic Contamination.
35:01 — Japan’s Law: Safety Testing & Rejuvenation Services.
39:58 — Next-Gen Immune Therapy: iPSCs vs Cancer & Aging.
44:59 — The In-Vivo Reprogramming Risk: Why It Fails.
49:59 — Infinite Cellular Supply: Pluripotency’s Power.
54:57 — Beyond Reprogramming: Solving the Extracellular Matrix.
Medical Disclaimer: